|
Name |
Dotriacontane
|
Molecular Formula | C32H66 | |
IUPAC Name* |
dotriacontane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C32H66/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-32H2,1-2H3
|
|
InChIKey |
QHMGJGNTMQDRQA-UHFFFAOYSA-N
|
|
Synonyms |
DOTRIACONTANE; n-Dotriacontane; 544-85-4; Bicetyl; 7KSV90RN23; NSC-6361; DICETYL; NSC 6361; EINECS 208-881-5; BRN 1783260; UNII-7KSV90RN23; Lacceran; AI3-52367; Dotriacontane, n-; MFCD00009411; Dotriacontane, 97%; 4-01-00-00595 (Beilstein Handbook Reference); WLN: 32H; DTXSID5052202; CHEBI:36020; HSDB 8362; NSC6361; Dotriacontane, analytical standard; CH3-[CH2]30-CH3; ZINC6920423; LMFA11000570; AKOS015903563; AS-10468; n-Dotriacontane 100 microg/mL in Hexane; DB-052589; n-Dotriacontane 100 microg/mL in n-Hexane; D0998; FT-0625591; D89756; Q151123; B8926297-132A-4B5D-B9C2-294F3F006246
|
|
CAS | 544-85-4 | |
PubChem CID | 11008 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 450.9 | ALogp: | 16.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 29 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 32 | QED Weighted: | 0.079 |
Caco-2 Permeability: | -5.525 | MDCK Permeability: | 0.00000176 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.041 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 102.99% |
Volume Distribution (VD): | 5.806 | Fu: | 0.57% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.111 |
CYP2C19-inhibitor: | 0.087 | CYP2C19-substrate: | 0.049 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.981 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.009 |
CYP3A4-inhibitor: | 0.108 | CYP3A4-substrate: | 0.008 |
Clearance (CL): | 4.186 | Half-life (T1/2): | 0.004 |
hERG Blockers: | 0.526 | Human Hepatotoxicity (H-HT): | 0.003 |
Drug-inuced Liver Injury (DILI): | 0.505 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.055 |
Skin Sensitization: | 0.984 | Carcinogencity: | 0.011 |
Eye Corrosion: | 0.997 | Eye Irritation: | 0.922 |
Respiratory Toxicity: | 0.131 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000437 | 0.968 | D00AOJ | 0.626 | ||||
ENC000576 | 0.940 | D00STJ | 0.405 | ||||
ENC000443 | 0.936 | D07ILQ | 0.387 | ||||
ENC000438 | 0.913 | D00FGR | 0.385 | ||||
ENC000436 | 0.904 | D0Z1QC | 0.347 | ||||
ENC000435 | 0.872 | D0Z5SM | 0.345 | ||||
ENC001705 | 0.841 | D01NTX | 0.343 | ||||
ENC000401 | 0.840 | D05ZPL | 0.309 | ||||
ENC000434 | 0.809 | D0T9TJ | 0.306 | ||||
ENC000541 | 0.797 | D0O1PH | 0.301 |